Gastric Cancer Market on Growth Trajectory: Novel Therapies Drive Momentum Through 2034

Strategic Insights -

The outlook for the gastric cancer treatment market appears favorable, fueled by progress in targeted therapies and immunotherapies. DelveInsight's Gastric Cancer Market Insights report provides a comprehensive understanding of current treatment practices, emerging gastric cancer drugs, market share of individual therapies, and current and forecasted gastric cancer market size from 2020 to 2034. The report segments the market into 7MM, including the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. Key players, such as Amgen, Jazz Pharmaceuticals, BeiGene, and AstraZeneca, are actively developing innovative gastric cancer drugs, which are anticipated to enter the market in the forecast period.

Key Takeaways:

  • The total gastric cancer market size is expected to grow positively by 2034, driven by emerging therapies and increasing incident cases.
  • The United States accounts for the largest market size of gastric cancer among the 7MM, while Germany, Italy, France, and Spain follow.
  • The total number of incident cases of gastric cancer (including GEJ) in the 7MM accounted for approximately 211K in 2024 and is expected to increase by 2034.
  • Key gastric cancer therapies in the pipeline include Bemarituzumab, ZIIHERA (zanidatamab), and ELVN-002, among others, which are expected to change the market.
  • Prominent companies, including Amgen, Jazz Pharmaceuticals, BeiGene, and AstraZeneca, are actively working on novel gastric cancer drugs, with several expected to enter the market in the forecast period.
  • The gastric cancer market is expected to witness the entry of multiple late-stage and early-stage novel therapies, driving the growth of the market.
  • AZD0405, an ADC agent, and TUKYSA (tucatinib), a kinase inhibitor, are some of the key therapies being evaluated in clinical trials.
  • Some of the key gastric cancer therapies have been granted orphan drug designation, showcasing the emphasis on providing relief to patients.

Statistics:

  • The global gastric cancer market size is expected to reach $14.32 billion by 2034 (Source: DelveInsight).
  • The United States market size is projected to reach $5.08 billion by 2034 (Source: DelveInsight).
  • The number of incident cases of gastric cancer (including GEJ) in the 7MM was approximately 211K in 2024 (Source: DelveInsight).
  • The gastric cancer market is expected to grow at a CAGR of 7.95% from 2020 to 2034 (Source: DelveInsight).

Sources:

  • DelveInsight Business Research LLP
  • Gastric Cancer Market Insights report
  • 7MM (United States, EU4, the United Kingdom, and Japan)
  • Gastric Cancer Market Size and Share Report